Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature.
Saved in:
| Title: | Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. |
|---|---|
| Authors: | Scarborough JA; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Eschrich SA; Biostatistics and Bioinformatics Program, Moffitt Cancer Center, Tampa, FL, USA., Torres-Roca J; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA., Dhawan A; Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. dhawana@ccf.org., Scott JG; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. scottj10@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2023 Apr 19; Vol. 7 (1), pp. 38. Date of Electronic Publication: 2023 Apr 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37076665 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Scarborough+JA%22">Scarborough JA</searchLink>; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Eschrich+SA%22">Eschrich SA</searchLink>; Biostatistics and Bioinformatics Program, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Torres-Roca+J%22">Torres-Roca J</searchLink>; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Dhawan+A%22">Dhawan A</searchLink>; Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. dhawana@ccf.org.<br /><searchLink fieldCode="AU" term="%22Scott+JG%22">Scott JG</searchLink>; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. scottj10@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2023 Apr 19; Vol. 7 (1), pp. 38. <i>Date of Electronic Publication: </i>2023 Apr 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37076665 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-023-00375-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 38 Titles: – TitleFull: Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Scarborough JA – PersonEntity: Name: NameFull: Eschrich SA – PersonEntity: Name: NameFull: Torres-Roca J – PersonEntity: Name: NameFull: Dhawan A – PersonEntity: Name: NameFull: Scott JG IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 04 Text: 2023 Apr 19 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |